COVID-19 Vaccine Covishield Linked to Rare Blood Clot Risk
AstraZeneca, the British pharmaceutical giant, has recently admitted in court documents that its COVID-19 vaccine, Covishield, can potentially cause a rare but serious condition called Thrombosis with Thrombocytopenia Syndrome (TTS). This condition, characterized by blood clots and low platelet counts, poses significant health risks. The revelation surfaced during a class action lawsuit in the UK,…